Literature DB >> 25527783

Elevated peripheral blood mononuclear cell-derived superoxide production in healthy young black men.

Shekhar H Deo1, Seth W Holwerda1, David M Keller2, Paul J Fadel3.   

Abstract

Several studies have demonstrated that blacks exhibit elevations in systemic oxidative stress. However, the source(s) and mechanism(s) contributing to the elevation in oxidative stress remain unclear. Given that peripheral blood mononuclear cells (PBMCs) can be a major source of NADPH oxidase-derived superoxide production, we tested the hypothesis that young black men demonstrate greater superoxide production and NADPH oxidase expression in PBMCs compared with whites. PBMCs were freshly isolated from whole blood in young normotensive black (n = 18) and white (n = 16) men. Intracellular superoxide production in PBMCs was measured using dihydroethidium fluorescence, protein expression of NADPH oxidase subunits, gp91(phox) (membranous) and p47(phox) (cytosolic) in PBMCs were assessed using Western blot analysis, and plasma protein carbonyls were measured as a marker of systemic oxidative stress. Black men showed elevated intracellular superoxide production (4.3 ± 0.5 vs. 2.0 ± 0.6 relative fluorescence units; black men vs. white men, P < 0.05), increased protein expression for gp91(phox) and p47(phox) (e.g., p47(phox): 1.1 ± 0.2, black men vs. 0.4 ± 0.1, white men, P < 0.05) in PBMCs and higher circulating protein carbonyl levels (22 ± 4 vs. 14 ± 2 nmol/ml; black men vs. white men, P < 0.05). Interestingly, a positive family history of hypertension in black men did not further enhance PBMC-derived intracellular superoxide production or NADPH oxidase subunit protein expression. These findings indicate that black men exhibit greater resting PBMC-derived superoxide production and an upregulation of the NADPH oxidase pathway with a possible contribution to increases in systemic oxidative stress.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  hypertension; racial differences; reactive oxygen species

Mesh:

Substances:

Year:  2014        PMID: 25527783      PMCID: PMC4346764          DOI: 10.1152/ajpheart.00784.2014

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  20 in total

1.  Racial differences in oxidative stress and inflammation: in vitro and in vivo.

Authors:  Deborah L Feairheller; Joon-Young Park; Kathleen M Sturgeon; Sheara T Williamson; Keith M Diaz; Praveen Veerabhadrappa; Michael D Brown
Journal:  Clin Transl Sci       Date:  2011-02       Impact factor: 4.689

Review 2.  NADPH oxidases in cardiovascular health and disease.

Authors:  Alison C Cave; Alison C Brewer; Anilkumar Narayanapanicker; Robin Ray; David J Grieve; Simon Walker; Ajay M Shah
Journal:  Antioxid Redox Signal       Date:  2006 May-Jun       Impact factor: 8.401

Review 3.  Reactive oxygen species in the neuropathogenesis of hypertension.

Authors:  Jeffrey R Peterson; Ram V Sharma; Robin L Davisson
Journal:  Curr Hypertens Rep       Date:  2006-06       Impact factor: 5.369

4.  Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation.

Authors:  Ana I Rodriguez-Perez; Ana Borrajo; Jannette Rodriguez-Pallares; Maria J Guerra; Jose L Labandeira-Garcia
Journal:  Glia       Date:  2014-11-06       Impact factor: 7.452

Review 5.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology.

Authors:  Karen Bedard; Karl-Heinz Krause
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 6.  Vascular NAD(P)H oxidases: specific features, expression, and regulation.

Authors:  Bernard Lassègue; Roza E Clempus
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-08       Impact factor: 3.619

Review 7.  NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.

Authors:  Tamara M Paravicini; Rhian M Touyz
Journal:  Diabetes Care       Date:  2008-02       Impact factor: 19.112

Review 8.  Atheroprotective effects of antioxidants through inhibition of mitogen-activated protein kinases.

Authors:  Moe Kyaw; Masanori Yoshizumi; Koichiro Tsuchiya; Yuki Izawa; Yasuhisa Kanematsu; Toshiaki Tamaki
Journal:  Acta Pharmacol Sin       Date:  2004-08       Impact factor: 6.150

Review 9.  Novel aspects of oxidative stress in cardiovascular diseases.

Authors:  Donald D Heistad; Yoshinobu Wakisaka; Jordan Miller; Yi Chu; Ricardo Pena-Silva
Journal:  Circ J       Date:  2008-12-26       Impact factor: 2.993

10.  Blockade of the renin-angiotensin system in African Americans with hypertension and cardiovascular disease.

Authors:  Elijah Saunders; James R Gavin
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jan-Feb       Impact factor: 3.738

View more
  12 in total

1.  Increased monocyte-derived reactive oxygen species in type 2 diabetes: role of endoplasmic reticulum stress.

Authors:  Robert M Restaino; Shekhar H Deo; Alan R Parrish; Paul J Fadel; Jaume Padilla
Journal:  Exp Physiol       Date:  2017-01-10       Impact factor: 2.969

Review 2.  Racial disparities in cardiovascular disease risk: mechanisms of vascular dysfunction.

Authors:  R Matthew Brothers; Paul J Fadel; David M Keller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-08-09       Impact factor: 4.733

3.  Contributions of endothelin-1 and l-arginine to blunted cutaneous microvascular function in young, black women.

Authors:  John D Akins; Rauchelle E Richey; Jeremiah C Campbell; Zachary T Martin; Guillermo Olvera; R Matthew Brothers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-12-17       Impact factor: 4.733

4.  Racial differences in microRNA and gene expression in hypertensive women.

Authors:  Douglas F Dluzen; Nicole Noren Hooten; Yongqing Zhang; Yoonseo Kim; Frank E Glover; Salman M Tajuddin; Kimberly D Jacob; Alan B Zonderman; Michele K Evans
Journal:  Sci Rep       Date:  2016-10-25       Impact factor: 4.379

5.  MicroRNAs Modulate Oxidative Stress in Hypertension through PARP-1 Regulation.

Authors:  Douglas F Dluzen; Yoonseo Kim; Paul Bastian; Yongqing Zhang; Elin Lehrmann; Kevin G Becker; Nicole Noren Hooten; Michele K Evans
Journal:  Oxid Med Cell Longev       Date:  2017-06-04       Impact factor: 6.543

6.  Epidemiological links between malaria parasitaemia and hypertension: findings from a population-based survey in rural Côte d'Ivoire.

Authors:  Ikenna C Eze; Fidèle K Bassa; Clémence Essé; Siaka Koné; Félix Acka; Véronique Laubhouet-Koffi; Dinard Kouassi; Jürg Utzinger; Bassirou Bonfoh; Eliézer K N'Goran; Nicole Probst-Hensch
Journal:  J Hypertens       Date:  2019-07       Impact factor: 4.844

7.  Cutaneous sensory nerve-mediated microvascular vasodilation in normotensive and prehypertensive non-Hispanic Blacks and Whites.

Authors:  Casey G Turner; James T Miller; Jeffrey S Otis; Matthew J Hayat; Arshed A Quyyumi; Brett J Wong
Journal:  Physiol Rep       Date:  2020-05

8.  Inhibition of iNOS augments cutaneous endothelial NO-dependent vasodilation in prehypertensive non-Hispanic Whites and in non-Hispanic Blacks.

Authors:  James T Miller; Casey G Turner; Jeffrey S Otis; Yesser Sebeh; Matthew J Hayat; Arshed A Quyyumi; Brett J Wong
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-10-30       Impact factor: 4.733

9.  Impact of acute antioxidant supplementation on vascular function and autonomic nervous system modulation in young adults with PTSD.

Authors:  Jennifer B Weggen; Ashley M Darling; Aaron S Autler; Austin C Hogwood; Kevin P Decker; Brandon Imthurn; Gina M Tuzzolo; Ryan S Garten
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-06-02       Impact factor: 3.210

10.  Can Vitamin D and L-Cysteine Co-Supplementation Reduce 25(OH)-Vitamin D Deficiency and the Mortality Associated with COVID-19 in African Americans?

Authors:  Sushil K Jain; Rajesh Parsanathan
Journal:  J Am Coll Nutr       Date:  2020-07-13       Impact factor: 3.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.